Published in J Virol on January 01, 1991
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol (1992) 3.22
Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol (2001) 2.85
Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J Virol (1995) 2.63
Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J (2001) 2.46
Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol (2001) 2.44
Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol (1999) 2.40
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A (1994) 2.25
Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc Natl Acad Sci U S A (2001) 2.24
EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol (1999) 2.07
Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J (1996) 2.03
The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol (1992) 1.91
The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol (1999) 1.80
Efficient feeder-free episomal reprogramming with small molecules. PLoS One (2011) 1.79
A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator. J Virol (1996) 1.76
The minimal replicator of Epstein-Barr virus oriP. J Virol (2000) 1.75
The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J (1998) 1.73
The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid (2007) 1.72
When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol (1991) 1.70
Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol (1999) 1.70
Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol (1998) 1.70
Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A (1991) 1.66
EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol (1992) 1.66
Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J Virol (1994) 1.64
Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol (2002) 1.58
Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol (1994) 1.55
Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J (1993) 1.53
Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J Virol (1994) 1.45
Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids. Mol Cell Biol (2001) 1.43
Multiple regions within EBNA1 can link DNAs. J Virol (1995) 1.42
Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J (2005) 1.40
Replication control of autonomously replicating human sequences. Nucleic Acids Res (1991) 1.36
Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast. EMBO J (2001) 1.36
The BAH domain facilitates the ability of human Orc1 protein to activate replication origins in vivo. EMBO J (2006) 1.34
EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin. J Virol (1992) 1.34
Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus. J Virol (2000) 1.33
Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin. Mol Cell Biol (1995) 1.31
Architecture of replication compartments formed during Epstein-Barr virus lytic replication. J Virol (2005) 1.31
Stable episomal maintenance of yeast artificial chromosomes in human cells. Mol Cell Biol (1996) 1.31
Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. J Virol (1997) 1.30
Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments. J Virol (2009) 1.25
Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol (1999) 1.23
Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res (1998) 1.23
Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J Virol (1993) 1.23
Replication and partitioning of papillomavirus genomes. Adv Virus Res (2008) 1.21
Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J Virol (2001) 1.21
Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Mol Cell Biol (2006) 1.18
Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA. J Virol (2003) 1.18
Derivation of human induced pluripotent stem cells for cardiovascular disease modeling. Circ Res (2011) 1.17
Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines. J Virol (2000) 1.17
Chromatin remodeling directly activates V(D)J recombination. Proc Natl Acad Sci U S A (1999) 1.16
Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol (2004) 1.15
Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J Virol (1998) 1.15
Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines. J Virol (1992) 1.14
Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication. J Virol (1992) 1.13
Cooperative assembly of EBNA1 on the Epstein-Barr virus latent origin of replication. J Virol (1996) 1.08
Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. J Virol (2001) 1.07
Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1. J Virol (2005) 1.06
Plasmid-like replicative intermediates of the Epstein-Barr virus lytic origin of DNA replication. J Virol (1996) 1.06
Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes. Nucleic Acids Res (2007) 1.06
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol (2004) 1.05
Different modes of human papillomavirus DNA replication during maintenance. J Virol (2006) 1.04
Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol (2012) 1.03
Epstein-Barr virus episome stability is coupled to a delay in replication timing. J Virol (2008) 1.02
Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. J Cancer Res Clin Oncol (2005) 1.02
DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov (2012) 1.02
Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer (2008) 1.00
Affinity proteomics to study endogenous protein complexes: pointers, pitfalls, preferences and perspectives. Biotechniques (2015) 1.00
Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J Virol (2004) 0.99
The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog (2015) 0.98
A chimera of EBNA1 and the estrogen receptor activates transcription but not replication. J Virol (1992) 0.98
A particular DNA structure is required for the function of a cis-acting component of the Epstein-Barr virus OriLyt origin of replication. Nucleic Acids Res (1997) 0.97
Epstein-Barr virus latent genes. Exp Mol Med (2015) 0.96
The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner. J Virol (2006) 0.96
The Epstein-Barr virus pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex. J Virol (2000) 0.96
An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency. J Virol (1999) 0.96
Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J Virol (2012) 0.95
The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome. J Virol (2012) 0.95
Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus. Proc Natl Acad Sci U S A (2012) 0.94
A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes. PLoS One (2007) 0.94
p53 protein is a suppressor of papillomavirus DNA amplificational replication. J Virol (1998) 0.93
The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins. Mol Cell Biol (2003) 0.92
The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance. Virology (2003) 0.92
The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements. J Virol (2001) 0.91
Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication. Nucleic Acids Res (2007) 0.90
A role for DNA polymerase θ in promoting replication through oxidative DNA lesion, thymine glycol, in human cells. J Biol Chem (2014) 0.90
Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. J Virol (1992) 0.89
Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus. J Virol (2001) 0.89
The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol (2001) 0.88
Papillomavirus contains cis-acting sequences that can suppress but not regulate origins of DNA replication. J Virol (1994) 0.87
Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein. J Biol Chem (2009) 0.87
DNA mismatch repair efficiency and fidelity are elevated during DNA synthesis in human cells. Mutat Res (2008) 0.86
Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data. Viruses (2013) 0.86
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (1985) 14.39
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A (1984) 10.91
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci U S A (1981) 9.27
Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences. Nature (1980) 7.92
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol (1985) 7.66
Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol (1976) 7.42
A quantitative in vitro focus assay for bovine papilloma virus. Virology (1980) 7.14
Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell (1988) 5.76
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell (1986) 5.13
Regulated replication of DNA microinjected into eggs of Xenopus laevis. Cell (1980) 4.24
Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. Science (1983) 4.04
Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol Cell Biol (1985) 4.03
Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol (1989) 3.15
Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol (1987) 2.98
Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol (1979) 2.78
Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell (1986) 2.58
Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids. Cell (1986) 2.35
Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell (1987) 2.22
Sequence analysis of Raji Epstein-Barr virus DNA. Virology (1988) 1.95
Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Annu Rev Cell Biol (1987) 1.93
Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells. Int J Cancer (1977) 1.67
Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine. Cell (1974) 1.65
S phase of the cell cycle. Science (1989) 1.59
Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis. Mol Biol Med (1988) 1.31
The bovine papillomavirus replicon. Ciba Found Symp (1986) 1.22
Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase. J Virol (1985) 0.91
Effective amplification of 20-kb DNA by reverse transcription PCR. Anal Biochem (1997) 1.08
The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true 'interaction' in podocyte. Kidney Int (2006) 0.85
Sol-gel technique for the preparation of beta-cyclodextrin derivative stationary phase in open-tubular capillary electrochromatography. Electrophoresis (2001) 0.75
[Progress in the treatment of nephrotic syndrome in children]. Zhonghua Er Ke Za Zhi (2017) 0.75
The FAD binding sites of human liver monoamine oxidases A and B: investigation of the role of flavin ribityl side chain hydroxyl groups in the covalent flavinylation reaction and catalytic activities. Biochim Biophys Acta (2000) 0.75
[Progress in treatment of nephrotic syndrome with melanocortin]. Zhonghua Er Ke Za Zhi (2016) 0.75